Colorectal cancer, once considered rare in young adults, now accounts for 1 in 5 diagnoses in those under 55. This "early-onset" colorectal cancer, identified in individuals under 50, is seeing rapidly increasing rates. Consequently, colonoscopies are now recommended at age 45, a significant shift from previous guidelines.
Dr. Laura Van Metre Baum, an oncologist at Dana-Farber Cancer Institute, notes that while lifestyle and environmental factors are suspected contributors, the exact reasons for the global increase in early-onset cases remain unclear. Factors like diets high in processed foods, low fiber intake, obesity, sedentary lifestyles, smoking, and alcohol consumption are known risk factors.
Younger patients are often diagnosed with more advanced-stage cancers, potentially leading to poorer outcomes. While some studies suggest better survival rates due to more intensive therapies, others show no difference or worse prognoses, particularly for those under 30 or 35.
Genetic mutations play a more significant role in early-onset cases, with 15-30% associated with hereditary cancer syndromes like Lynch syndrome. New somatic mutations are also being identified in these tumors.
Treatment typically involves surgery, chemotherapy, and radiation, with immunotherapy as a possibility depending on specific mutations. Treatment intensity is adjusted based on the cancer's specifics and the patient's ability to tolerate therapy.
While a healthy lifestyle is beneficial, cancer prevention is complex. Awareness of symptoms, such as abdominal pain, weight loss, or changes in bowel habits, and regular screening are crucial. Colonoscopies are vital preventive tools, allowing for the detection and removal of precancerous polyps.
Younger patients may face unique challenges, including fertility concerns, emotional impacts, and effects on family life, academics, and finances. Early diagnosis remains key to increasing treatment options and the chances of recovery.